Are biochemical markers for bone turnover clinically useful for monitoring therapy in individual osteoporotic patients?

Bone. 2000 Jun;26(6):551-2. doi: 10.1016/s8756-3282(00)00270-2.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Alendronate / therapeutic use*
  • Biomarkers / blood*
  • Bone Density
  • Bone Remodeling*
  • Drug Monitoring*
  • Female
  • Hormone Replacement Therapy*
  • Humans
  • Male
  • Osteoporosis / drug therapy*
  • Osteoporosis / physiopathology
  • Postmenopause

Substances

  • Biomarkers
  • Alendronate